These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17620960)

  • 1. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition.
    Kobayashi N; Honda T; Yoshida K; Nakano S; Ohno T; Tsubokou Y; Matsuoka H
    Atherosclerosis; 2006 Jul; 187(1):92-100. PubMed ID: 16214149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effect of benidipine on cardiac performance and remodeling in failing rat hearts.
    Ohno T; Kobayashi N; Yoshida K; Fukushima H; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):224-30. PubMed ID: 18188157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
    J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
    Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
    J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway.
    Otto A; Fontaine J; Berkenboom G
    J Cardiovasc Pharmacol; 2006 Jul; 48(1):842-9. PubMed ID: 16891913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats.
    Tamura T; Jamous MA; Kitazato KT; Yagi K; Tada Y; Uno M; Nagahiro S
    J Hypertens; 2009 Jun; 27(6):1284-92. PubMed ID: 19307983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
    Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
    Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
    Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
    Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.
    Yang HY; Kao PF; Chen TH; Tomlinson B; Ko WC; Chan P
    J Clin Pharmacol; 2007 Mar; 47(3):397-403. PubMed ID: 17322151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.